Psychiatry Research
Baylor College of Medicine
Houston, TX, US
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States


Advanced Training from Harvard Medical School
Ph.D. from University Of Texas Medical Branch Affiliate Hospitals
M.S. from University Of North Texas
B.S. from Texas A&M University Commerce

Professional Interests

  • Neuropharmacology
  • Neuropsychiatry
  • Behavioral Pharmacology

Professional Statement

Dr. De La Garza conducts laboratory studies in humans to investigate the safety and efficacy of novel pharmacological and behavioral treatments for cocaine and methamphetamine use disorders. He is also interested in cancer prevention as it relates to smoking cessation research, and is evaluating the neurobiological and behavioral effects of electronic cigarettes in cigarette smokers. Techniques used include behavioral assays, physiological measures, virtual reality/cue-reactivity, and neuroimaging. He has published over 100 peer-reviewed articles and several book chapters.

Selected Publications


College on Problems of Drug Dependence
CPDD seeks to advance the understanding of molecular-neurobiological aspects of addictive disorders and, by the application of new scientific knowledge, to improve and develop treatments utilizing novel behavioral and pharmacological therapies.
American College of Neuropsychopharmacology
ACNP is the nation's premier professional society in brain, behavior, and psychopharmacology research.
Society for Research on Nicotine & Tobacco
The mission of the Society is to stimulate the generation of new knowledge concerning nicotine in all its manifestations - from molecular to societal.
National Hispanic Science Network
NHSN is dedicated to improving the health equity of Hispanics by Increasing the amount, quality, and dissemination of interdisciplinary translational research and Fostering the development and advancement of Hispanic scientists to promote future leaders.